InnoCare Pharma Ltd. (INCPF) Income Statement
InnoCare Pharma Ltd. Income Statement
Last quarter (Q3 2026), InnoCare Pharma Ltd.'s total revenue was $961.90M, an increase of 150.65% from the same quarter last year. In Q3, InnoCare Pharma Ltd.'s net income was $409.28M. See InnoCare Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.30B | $ 1.01B | $ 738.54M | $ 625.40M | $ 1.04B | |
| $ 2.01B | $ 871.01M | $ 610.10M | $ 482.01M | $ 977.37M | |
| $ 1.57B | $ 1.40B | $ 1.26B | $ 1.25B | $ 1.16B | |
| Depreciation and Amortization | $ 115.29M | $ 106.26M | $ 92.62M | $ 68.40M | $ 33.71M |
| $ 555.89M | $ -442.92M | $ -516.55M | $ -808.28M | $ 16.23M | |
| $ 440.59M | $ -525.78M | $ -651.15M | $ -770.40M | $ -193.87M | |
| $ 198.18M | $ 73.19M | $ 6.95M | $ -123.32M | $ 0.00 | |
| $ 638.77M | $ -452.59M | $ -644.21M | $ -893.73M | $ -20.12M | |
| $ 625.84M | $ -440.63M | $ -631.26M | $ -886.59M | $ -64.55M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.36 | $ -0.26 | $ -0.37 | $ -0.60 | $ -0.05 |
| Diluted EPS | $ 0.36 | $ -0.26 | $ -0.37 | $ -0.60 | $ -0.05 |
| Weighted Average Shares Outstanding | 1.76B | 1.69B | 1.71B | 1.48B | 1.37B |
| Weighted Average Shares Outstanding (Diluted) | 1.76B | 1.69B | 1.71B | 1.48B | 1.37B |
Currency in CNY
